Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore

Hematol Oncol. 2025 Jan;43(1):e70030. doi: 10.1002/hon.70030.

Authors

Jing Yuan Tan^{1

2}, Victor Wei Teik Ling³, Lawrence Cheng Kiat Ng^{1

2}, Cindy Krisnadi^{1

2}, Melinda Si Yuan Tan^{1

2}, Nicholas Francis Grigoropoulos^{1

2}, Shin Yeu Ong^{1

2}, Chandramouli Nagarajan^{1

2}, Jeffrey Kim Siang Quek^{1

2}, Hein Than^{1

2}, Joanne Lee³, Esther Chan³, Lip Kun Tan³, William Ying Khee Hwang^{1

2}, Yeow Tee Goh^{1

2}, Yeh Ching Linn^{1

2}, Liang Piu Koh³, Aloysius Yew Leng Ho^{1

2}, Francesca Wei Inng Lim^{1

2}, Michelle Limei Poon³, Yunxin Chen^{1

2}

Affiliations

¹ Department of Hematology, Singapore General Hospital, Singapore, Singapore.
² National Cancer Centre Singapore, Singapore, Singapore.
³ Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.

PMID: 39729576
DOI: 10.1002/hon.70030

No abstract available

Keywords: C‐MYC/BCL2; double expressor lymphoma; inferior outcomes; transplant.

Publication types

Letter